IMPEGNO nel SOCIALE
RICONOSCIMENTI
BREVETTI
Cerca nel Blog
Pubblicazioni scientifiche
FOCUS ONL’attività scientifica e di ricerca del prof. Gianluca Franceschini è documentata anche da numerose pubblicazioni attinenti al settore scientifico disciplinare MED/18 Chirurgia Generale, riguardanti prevalentemente il trattamento chirurgico dei tumori mammari, con particolare focus sulla chirurgia oncoplastica, le tecniche di mastectomia con ricostruzione e l’utilizzo di materiali biocompatibili in chirurgia conservativa. In particolare il prof. Franceschini è stato tra i primi ricercatori a dimostrare la validità e l’efficacia oncologica ed estetica delle tecniche di chirurgia oncoplastica nel trattamento conservativo delle neoplasie della mammella con il lavoro scientifico “Oncoplastic techniques in the conservative surgical treatment of breast cancer” pubblicato sulla rivista “Breast Cancer” nel 2000 (Autori: Masetti R, Pirulli PG, Magno S, Franceschini G, Chiesa F, Antinori A. - Breast Cancer. 2000;7(4):276-80. doi: 10.1007/BF02966389).
Le pubblicazioni scientifiche comprendono:
- Lavori “in extenso” su riviste scientifiche nazionali ed internazionali.
- Volumi editi, trattati e collane editoriali nazionali ed internazionali
- Abstracts su riviste scientifiche nazionali ed internazionali.
- Lavori, abstracts, poster e comunicazioni editi in atti di congressi nazionali ed internazionali.
I lavori scientifici presenti su “SCOPUS” (Elsevier) (ID SCOPUS: 23027478400) sono oltre 200.
Consulta il curriculum vita esteso, presente in home page, per conoscere l'intero elenco dei lavori in extenso su riviste scientifiche, dei volumi editi, dei trattati e delle collane, degli abstracts su riviste scientifiche e dei lavori, abstracts, poster e comunicazioni editi in atti di congressi nazionali ed internazionali dal Prof. Gianluca Franceschini.
Pubblicazioni
FOCUS ONL’attività di ricerca è documentata da pubblicazioni scientifiche attinenti al settore scientificodisciplinare MED/18 Chirurgia Generale, comprendenti:
- Lavori “in extenso” su riviste scientifiche nazionali ed internazionali.
- Capitoli in volumi editi in italiano ed inglese.
- Abstracts su riviste scientifiche nazionali ed internazionali.
- Abstracts, poster, lavori e comunicazioni editi in atti di congressi nazionali ed internazionali.
L’impact Factor (IF) complessivo delle pubblicazioni è di 244,951 (sec. ISI Web of Knowledge, Journal Citation Reports, Science Edition 2019; Thomson Reuters).
I lavori presenti su “PUBMED” (ID ORCID: 0000-0002-2950-3395), al 31 ottobre 2020, sono 103 di cui 101 riguardanti la patologia mammaria.
I lavori presenti su “SCOPUS” (ID SCOPUS: 23027478400), al 31 ottobre 2020, sono 112 con un H-Index di 15 e 867 citazioni totali.
Ha pubblicato come Autore 15 capitoli di libro in volumi editi nazionali ed internazionali riguardanti la patologia mammaria; 6 capitoli sono editi a primo nome.
LAVORI “IN EXTENSO” SU RIVISTE SCIENTIFICHE
Timectomia video-assistita per via sternotomica con incisione cutanea trasversale sopraxifoidea. P. Granone, S. Margaritora, A. Cesario, A. Verbo, D. Galetta, G. Franceschini, A. Evoli, A. P. Batocchi, A. Picciocchi. Chirurgia. 1998; 11: 154 -157.
2. Il ruolo della chirurgia nel trattamento della malattia diverticolare del colon. G. Netri, A. Verbo, C. Coco, S. Cogliandolo, L. Salvadori, M. Taurchini, D’Andrilli, G. Franceschini, L. Carbone, L. Gliosci, A. Picciocchi. Italian Journal of Coloproctology. 1998; Vol. 17, No. 2: 54-55.
3. Axillary Lymphadenectomy. A. Picciocchi, D. Terribile, G. Franceschini. Ann. Ital. Chir. 1999; May-Jun; 70(3): 349 -353. (IF: 0,793)
4. Noduli polmonari solitari: il ruolo della video-toracoscopia. P. Granone, S. Margaritora, A. D’Andrilli, P.L. Bonatti, A. Cesario, A. Verbo, G. Franceschini. Arch. Chir. Torac. Cardiovasc, 2000; 22: 95 - 98.
5. Oncoplastic techniques in the conservative surgical treatment of breast cancer. R. Masetti, P.G. Pirulli, S. Magno, G. Franceschini, F. Chiesa, A. Antinori. Breast Cancer. 2000. Vol.7, No 4: 276 -280. (IF: 2.695)
6. MRI in phyllodes tumor of the breast. Case reports. M. Costantini, A. Magistrelli, G. Franceschini, A. Mule, G. Pastore, P. Belli. Rays. 2002. 27; 4: 313 -318.
7. Suspected cup sindrome. Diagnostic imaging of a misunderstood breast tumor for its uncommon location. Canadè, A. Magistrelli, R. Lombardi, M. Costantini, G. Franceschini, P. Belli. Rays. 2003. 28; 4: 379 -385.
8. Neoadjuvant concurrent chemotherapy and radiotherapy in Non-Small Cell Lung Cancer. S. Ramella, M. Ciresa, M. Massaccesi, G. Franceschini, R. M. D’Angelillo, L. Trodella. Rays. 2004. 29; 4: 439-443.
9. Phyllodes tumor of the breast: Magnetic Resonance Imaging findings and surgical treatment. G. Franceschini, R. Masetti, A. Brescia, A. Mulè, P. Belli, M. Costantini, A. Magistrelli, A. Picciocchi. Breast J. 2005. Vol. 11 (2): 144-145. (IF: 1.991)
10. Synchronous bilateral Paget's disease of the nipple associated with bilateral breast carcinoma. G. Franceschini, R. Masetti, D. D'Ugo, F. Palumbo, P. D'Alba, A. Mule, M. Costantini, P. Belli, A. Picciocchi. Breast J. 2005. Vol.11 (5): 355-6. (IF: 1.991)
11. Surgical treatment and MRI in phyllodes tumors of the breast: our experience and review of the literature. G. Franceschini, D. D'Ugo, R. Masetti, F. Palumbo, P. D'Alba, A. Mule, M. Costantini, P. Belli, A. Picciocchi. Ann Ital Chir. 2005. Vol. 76 (2): 127-40. (IF: 0,793)
12. Synchronous Bilateral Breast Carcinoma in a 50-Year-Old Man with 45,X/46,XY Mosaic Karyotype: Report of a Case. G. Franceschini, P. D'Alba, M. Costantini, A. Magistrelli, P. Belli, A. Mule, C. Coco, A. Picciocchi. Surg Today. 2006. Vol. 36 (1): 71-5. (IF: 1.878)
13. Conservative Treatment with Nipple-Areolar Resection for Subareolar breast Cancer. G. Franceschini, R. Masetti, P. D'Alba, G. Consorti, A. Picciocchi. Breast J. 2006. Vol. 12 (1): 91-92. (IF: 1.991)
36 14. Conservative management of an unusual Paget's disease of the nipple: a case report and review of the literature. G. Franceschini, R. Masetti, R. Persiani, D. D'Ugo, A. Di Leone, A. Mule, M. Costantini, A. Picciocchi. Chirurgia. febbraio 2006. Vol. 19 (1): 87-91.
15. Oncoplastic techniques in the conservative surgical treatment of breast cancer. An overview. R. Masetti, A. Di Leone, G. Franceschini, S. Magno, D. Terribile, M.C. Fabbri, F. Chiesa. Breast J. 2006 Sep-Oct; 12 (5 Suppl 2):S174-80. (IF: 1.991)
16. Characterization of solid breast masses: use of the sonographic breast imaging reporting and data system lexicon. M Costantini, P Belli, R Lombardi, G Franceschini, A Mulè, L Bonomo. J Ultrasound Med. 2006 May; 25 (5): 649-59. (IF: 1.759)
17. Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: report of a case and review of the literature. G Franceschini, A Manno, A Mule, A Verbo, G Rizzo, D Sermoneta, L Petito, P D'alba, C Maggiore, D Terribile, R Masetti, C Coco. BMC Cancer. 2006 Jul 19; 6:193 (1-7). (IF:3.150)
18. Axillary lymph nodes microcalcifications in metastatic breast cancer. Case report and literature review. G. Franceschini, R. Masetti, M. Costantini, P. Belli, A. Picciocchi. Chirurgia. 2006. Vol. 19 (4): 293-96.
19. A giant papillary carcinoma of the breast treated with mastectomy and bipedicled TRAM flap. Franceschini G, Salgarello M, Masetti R, Belli P, Costantini M, Barone Adesi L, Picciocchi A. Ann Ital Chir. 2006. Vol. 77 (4): 341-44. (IF: 0,793)
20. Management of locally advanced breast cancer: mini-review. G. Franceschini, D. Terribile, C. Fabbri, S. Magno, P. D’Alba, F. Chiesa, A. Di Leone, R. Masetti. Minerva Chirurgica. Aug 2007. Vol 62 (4): 249-255. (IF: 0.765)
21. Solid breast mass characterisation: use of the sonographic BI-RADS classification. Costantini M, Belli P, Ierardi C, Franceschini G, La Torre G, Bonomo L. Radiol Med. 2007. 112: 877-894. (IF: 2.000)
22. Ductal carcinoma in situ: surgical theraphy. A mini review. G. Franceschini, D. Terribile, S. Magno, C. Fabbri, P.F. D’Alba, F. Chiesa, A. Di Leone, R. Masetti. Chirurgia. October 2007. Vol 20; n. 5: 277-280.
23. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach. G. Franceschini, D. Terribile, S. Magno, C. Fabbri, P.F. D’Alba, F. Chiesa, A. Di Leone, R. Masetti. European Review for Medical Pharmacological Sciences. 2007. Vol 11: 283-289. (IF: 3.024)
24. Conservative treatment of the central breast cancer with nipple-areolar resection: an alternative oncoplastic technique. G. Franceschini, D. Terribile, S. Magno, C. Fabbri, P.F. D’Alba, F. Chiesa, A. Di Leone, R. Masetti. G Chir. Jan-Feb 2008. Vol 29 – n. 1-2: 23-27.
25. Congenital tumors of the retrorectal space in the adult: report of two cases and review of the literature. C. Coco, A. Manno, C. Mattana, A. Verbo, D. Sermoneta, G. Franceschini, A. De Gaetano, L. M. Larocca, L. Petito, G. Pedretti, G. Rizzo, C. Lodoli and D. D’Ugo. Tumori. 2008 Jul-Aug. 94 (4): 602-607. (IF: 1.707)
26. Current controversies in the treatment of ductal carcinoma in situ of the breast. G. Franceschini, D. Terribile, S. Magno, C. Fabbri, P. D’Alba, F. Chiesa, A. Di Leone, R. Masetti. Ann Ital Chir. 2008. 79 (3): 151-155. (IF: 0,793)
27. Progresses in the treatment of early breast cancer: a mini-review”. G. Franceschini, D. Terribile, C. Fabbri, S. Magno, P. D’Alba, F. Chiesa, A. Di Leone, R. Masetti. Ann Ital Chir. 2008. 79 (1): 17-22. (IF: 0,793)
28. Conservative and radical oncoplastic approaches in the surgical treatment of breast cancer. G. Franceschini, S. Magno, C. Fabbri, F. Chiesa, A. Di Leone, F. Moschella, I. Scafetta, A. Scaldaferri, S. Frigomeni, L. Adesi Barone, D. Terribile, M. Salgarello, R. Masetti. European Review for Medical Pharmacological Sciences. 2008. 12 (6):387-396. (IF: 3.024)
29. Accessory nipple reconstruction following a central quadrantectomy: a case report. Magno S, Terribile D, Franceschini G, Fabbri C, Chiesa F, Di Leone A, Masetti R. Cases J. 2009 Jan 8. 2 (1): 32.
30. Breast MRI in a case of “early onset” lactating adenoma. S. Magno, D. Terribile, G. Franceschini, C. Fabbri, P.F. D’Alba, F. Chiesa, A. Di Leone, M. Costantini, P. Belli, R. Masetti. Breast J. 2009 Jan-Feb. 15 (1): 105-6. (IF: 1.991)
31. Early onset lactating adenoma and the role of breast MRI: a case report S. Magno, D. Terribile, G. Franceschini, C. Fabbri, P.F. D’Alba, F. Chiesa, A. Di Leone, M. Costantini, P. Belli, R. Masetti. J Med Case Rep. 2009 Jan 30. 3: 43.
32. Conservative treatment of a rare case of multifocal adenoid cystic carcinoma of the breast. Case report and literature review. G. Franceschini, I. Scaletta, S. Magno, C. Fabbri, F. Chiesa, A. Di Leone, F. Moschella, A. Scaldaferri, S. Frigomeni, V. Vellone, A. Mulè, D. Terribile, R. Masetti. Med Sci Monit. 2010 Feb 26;16 (3): CS33-39. (IF: 1.918)
33. Il ruolo della cellulosa ossidata rigenerata. La chirurgia oncoplastica della mammella. R. Masetti, G. Franceschini. La Sala Operatoria. Febbraio 2010; 39-42.
34. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. M. Costantini, P. Belli, P. Rinaldi, E. Bufi, G. Giardina, G. Franceschini, G. Petrone, L. Bonomo. Clinical Radiology. 2010. 65; 1005- 1012. (IF: 2.118)
35. Inverted T skin-reducing mastectomy with immediate implant reconstruction using the submuscular-subfascial pocket. M. Salgarello, G. Visconti, L. Barone-Adesi, G. Franceschini, S. Magno, D. Terribile, R. Masetti. Plast Reconstr Surg. 2012 Jul. 130 (1): 31-41. (IF: 4.209)
36. A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer.Nardone L, Valentini V, Marino L, De Santis MC, Terribile D, Franceschini G, Balducci M, Mantini G, Mattiucci G, Mulè A, Belli P, Masetti R. Tumori. 2012 Jan-Feb. 98 (1): 79-85. (IF: 1.707)
37. The role of oxidized regenerate cellulose to prevent cosmetic defects in oncoplastic breast surgery. Franceschini G, Visconti G, Terribile D, Fabbri C, Magno S, Di Leone A, Salgarello M, Masetti R. Eur Rev Med Pharmacol Sci. 2012 Jul;16 (7): 966-71. (IF: 3.024) 38
38. Update on oncoplastic breast surgery. Franceschini G; Terribile D; Magno S; Fabbri C; Accetta C; Di Leone A; Moschella F; Barbarino R; Scaldaferri A; D’archi S; Carvelli M; Bove S; Masetti R. Eur Rev Med Pharmacol Sci. 2012 Nov. 16 (11): 1530-40. (IF: 3.024)
39. The use of oxidized regenerated cellulose in oncoplastic breast surgery: “warning” for postoperative follow-up! Franceschini G, Visconti G, Masetti R. Ann. Ital. Chir. 2013. 84: 483-484. (IF: 0.793)
40. Oncoplastic Breast Surgery with Oxidized Regenerated Cellulose: Appraisals Based on Five-year Experience. Franceschini G, Visconti G, Masetti R. Breast J. Jul-Aug 2014. 20 (4): 447-8. Epub 2014 May 26 (IF: 1.991)
41. The Breast Unit. Update on advantages and the open issues. Franceschini G, Di Leone A, Masetti R. Ann Ital Chir. 2014. 85; 5; 407-412. (IF: 0.793)
42. Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study. Nardone L, Diletto B, De Santis MC, D' Agostino GR, Belli P, Bufi E, Franceschini G, Mulé A, Sapino A, Terribile D, Valentini V. Breast. 2014 Oct. 23 (5):597-602. (IF: 3.754)
43. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment. Bufi E, Belli P, Di Matteo M, Terribile D, Franceschini G, Nardone L, Petrone G, Bonomo L. Eur J Radiol. 2014 Sep. 83 (9):1631-8. (IF: 2.687)
44. Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors. Belli P, Costantini M, Bufi E, Giardina GG, Rinaldi P, Franceschini G, Bonomo L. Radiol Med. 2015 Mar. 120 (3): 268-76. (IF: 2.000)
45. Role of the apparent diffusion coefficient in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Bufi E, Belli P, Costantini M, Cipriani A, Di Matteo M, Bonatesta A, Franceschini G, Terribile D, Mulé A, Nardone L, Bonomo L. Clin Breast Cancer. 2015 Oct. 15 (5): 370-80. (IF: 2.647)
46. AMAROS Study: overall survival in breast cancer subtypes. Orlandi A, Franceschini G, Astone A, Masetti R, Barone C. Clin Oncol (R Coll Radiol). 2015 Aug. 27 (8): 485-6. (IF: 3.113)
47. Update on the surgical management of breast cancer. Franceschini G, Sanchez AM, Di Leone A, Magno S, Moschella F, Accetta C, Natale M, Di Giorgio D, Scaldaferri A, D'Archi S, Scardina L, Masetti R. Ann Ital Chir. 2015. Mar-Apr. 86 (2): 89-99. (IF: 0.793)
48. Contralateral breast symmetrisation in immediate prosthetic breast reconstruction after unilateral nipple-sparing mastectomy: the tailored reduction/augmentation mammaplasty. Salgarello M, Visconti G, Barone-Adesi L, Franceschini G, Masetti R. Arch Plast Surg. 2015 May. 42 (3): 302-8.
49. Oxidized regenerated cellulose in breast surgery: experimental model. Franceschini G, Visconti G, Sanchez AM, Di Leone A, Salgarello M, Masetti R. J Surg Res. 2015 Sep. 198 (1): 237-44. (IF: 1.841).
50. Quadrantectomy with oxidized regenerated cellulose ("QUORC"): an innovative oncoplastic technique in breast conserving surgery. Franceschini G, Sanchez AM, Visconti G, Di Leone A, Salgarello M, Masetti R. Ann Ital Chir. 2015. 86: 548-552 (IF: 0.793)
51. Mammographic and Ultrasonographic Findings of Oxidized Regenerated Cellulose in Breast Cancer Surgery: A 5-Year Experience. Giuliani M, Fubelli R, Patrolecco F, Rella R, Borelli C, Buccheri C, Di Giovanni SE, Belli P, Romani M, Rinaldi P, Bufi E, Franceschini G, Bonomo L. Clin Breast Cancer. 2015 Oct. 15 (5): e249-56. (IF: 2.647)
52. New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient G. Franceschini, A. Martin Sanchez, A. Di Leone, S. Magno, F. Moschella, C. Accetta, R. Masetti. G Chir. July-August 2015. 36 (4): 145-152.
53. YB-1 in breast cancer. Our laboratory data. Arena V, Riccardi M, Pennacchia I, Franceschini G, Di Leone A, Masetti R. Eur J Surg Oncol. 2016 Mar. 42 (3): 433-434. (IF: 3.959)
54. Integrated breast cancer surgical treatment: novel aspects of minimally invasive treatments. Franceschini G, Sanchez AM, Di Leone A, Magno S, Moschella F, Accetta C, Natale M, Masetti R. Minerva Chir. April 2016. 71 (2); 146-155. (IF: 0.765)
55. Septum-based cervical lymph-node free flap in rat: a new model. Visconti G, Brunelli C, Mulè A, Franceschini G, Chen HC, Masetti R, Salgarello M. J Surg Res. March 2016. 201 (1): 1-12. (IF: 1.841)
56. Penile cancer metastasizing to the breast: a case report. Franceschini G, Sanchez A, Di Leone A, Scaldaferri A, Ferrucci M, Mulè A, Costantini M and Masetti R. J Med Case Rep. 2016 Mar 9;10 (1): 53. doi: 10.1186/s13256-016-0829-3.
57. Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery. Giuliani M, Rella R, Fubelli R, Patrolecco F, Di Giovanni SE, Buccheri C, Padovano F, Belli P, Romani M, Rinaldi P, Bufi E, Franceschini G, Bonomo L. Radiol Med. 2016 Sep;121(9):688-95. doi: 10.1007/s11547-016-0656-z. (IF: 2.000)
58. Reduction mammoplasty using oxidized regenerated cellulose as a filler in breast conservation surgery. Franceschini G, Sanchez AM, Visconti G, Di Leone A, D'Archi S, Mulè A, Santoro A, Salgarello M, Masetti R. Ann Ital Chir. 2016;87:292-297. (IF: 0.793)
59. The Venous Lymph Node Flap: Concepts, Experimental Evidence, and Potential Clinical Implications. Visconti G, Constantinescu T, Chen PY, Salgarello M, Franceschini G, Masetti R, Chen HC. J Reconstr Microsurg. 2016 Oct;32 (8): 625-31. (IF: 1.841)
60. Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer. Bufi E, Belli P, Di Matteo M, Giuliani M, Tumino M, Rinaldi P, Nardone L, Franceschini G, Mulé A, Bonomo L. Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16) 30162-8. (IF: 2.647)
61. Mastectomy in precision oncology era: myth or reality? Franceschini G, Orlandi A, Sanchez AM, Calegari MA, Masetti R. Translational Cancer Research. Vol 5, Supplement 3 September 2016). S544 – S545. (IF: 0.986)
62. Role of DWI assessing nodal involvement and response to neoadjuvant chemotherapy in advanced breast cancer. Belli P, Bufi E, Buccheri C, Rinaldi P, Giuliani M, Romani M, Fabrizi G, D'angelo A, Brunelli C, Mule' A, Franceschini G, Colosimo C. Eur Rev Med Pharmacol Sci. 2017 Feb;21(4):695-705. (IF: 3.024)
63. A giant phyllodes tumor of the breast causing severe disfigurement. Franceschini G, Di Giorgio D, D'Archi S, Di Leone A, Sanchez AM, Masetti R. A case report. Ann Ital Chir. 2017 Jan 20;6. (IF: 0.793)
64. New challenges in multimodal workout of locally advanced breast cancer. Sanchez AM, Franceschini G, Orlandi A, Di Leone A, Masetti R. Surgeon. 2017 Jun 14.pii: S1479- 666X(17)30092-6. (IF: 2.311)
65. Metastatic giant malignant phyllodes tumor of the breast. Sanchez AM, Franceschini G, Di Giorgio D, Masetti R. Breast J. 2017 Nov 15. doi: 10.1111/tbj.12960. (IF: 1.991)
66. Update of current evidences in breast cancer multidisciplinary management (Preface). Franceschini G, Sánchez AM, Masetti R. Translational Cancer Research. Vol 7, Supplement 3 (April 2018); S264-265. (IF: 0.986)
67. Diagnosis and management of breast lymphoma: a single- institution retrospective analysis Orlandi A, Sanchez AM, Calegari MA, D’Archi S, Santoro A, Di Leone A, Mulè A, Arena V, Masetti R, Barone C, Franceschini G. Translational Cancer Research. Vol 7, Supplement 3 (April 2018); S272-280. (IF: 0.986)
68. The modern concept of breast conserving surgery. Natale M, Di Leone A, Scardina L, D’Archi S, Masetti R, Franceschini G. Translational Cancer Research. Vol 7, Supplement 3 (April 2018); S281-294. (IF: 0.986)
69. Current weaknesses of breast conserving strategies after neoadjuvant chemotherapy in breast cancer treatment. Sanchez AM, Franceschini G, Scardina L, Di Leone A, Masetti R. Translational Cancer Research. Vol 7, Supplement 3 (April 2018); S356-364. (IF: 0.986)
70. New techniques for sentinel node biopsy in breast cancer. Ferrucci M, Franceschini G, Douek M. Translational Cancer Research. Vol 7, Supplement 3 (April 2018); S405-417. (IF: 0.986)
71.Taking one step backward to take two steps forward: the importance of breast tumor phenotype in MRI-based prediction of response. Bufi E, Belli P, Rosignuolo M, Petta F, Grippo C, Rinaldi P, Giuliani M, Romani M, Franceschini G, Manfredi R. Translational Cancer Research. Vol 7, Supplement 3 (April 2018); S424-432. (IF: 0.986)
72. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer. Franceschini G, Di Leone A, Natale M, Sanchez AM, Masetti R Ann. Ital. Chir. 2018 89, 3: 290. (0,793)
73. The use of a new hemostatic preparation made of the cellulose derivatives in surgery: “warning” for postoperative complications! Franceschini G, Di Leone A, Visconti G, Masetti R. J. Life Sci. Biomed., 9(2): 42-44, 2019; pii:S225199391900007-9.
74. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution! Fanceschini G, Di Leone A, Masetti R. Am J Surg. 2019 Nov;218(5):1031-1032. doi: 10.1016/j.amjsurg.2019.01.019. (IF: 2.125)
41 75. What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy! Franceschini G, Di Leone A, Masetti R. Transl Behav Med. 2019 Jan 29. doi: 10.1093/tbm/ibz006. (IF: 2.864)
76. Transaxillary Nipple-Sparing Mastectomy, Lymphadenectomy and Direct-to-Implant Submuscular Breast Reconstruction Using Endoscopic Technique: A Step toward the "Aesthetic Mastectomy". Visconti G, Franceschini G, Barone-Adesi L, Bianchi A, Masetti R, Salgarello M. Plast Reconstr Surg. 2019 May;143(5):1122e-1123e. doi: 10.1097/PRS.0000000000005542. (IF: 4.209)
77. "Warning" to postoperative complications when using hemostatic agents! Franceschini G, Visconti G, Di Leone A, Masetti R. Acta Neurochir (Wien). 2019 May;161(5):871-872. doi: 10.1007/s00701-019-03863-y. (IF: 1.817)
78. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. Ann Ital Chir. 2019;90:1-2.Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R. Ann Ital Chir. 2019; 90:1-2. (0.793)
79. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients! Franceschini G, Di Leone A, Masetti R. Patient Educ Couns. 2019 Aug;102(8):1573-1574. doi: 10.1016/j.pec.2019.03.006. (IF: 2.607)
80. Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome. Marazzi F, Masiello V, Marchesano D, Boldrini L, Luzi S, Ferrara PE, Amabile E, Piccari D, Landi F, Moschella F, Franceschini G, Masetti R, Mantini G, Valentini V, Smaniotto D. Tumori. 2019 Aug;105(4):319-330. doi: 10.1177/0300891619839287. (IF: 1.707)
81. Bilateral risk-reducing mastectomy in BRCA mutation carriers: A difficult decision-making. Franceschini G, Masetti R. Breast J. 2019 May;25(3):564-565. doi: 10.1111/tbj.13287. Epub 2019 Apr 9. (IF: 1.991)
82. What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers. Franceschini G, Masetti R. Eur J Breast Health. 2019 Apr 1;15(2):135- 136. doi: 10.5152/ejbh.2019.4651. eCollection 2019 Apr.
83. Steps to follow in oncoplastic breast surgery to optimise oncological and cosmetic outcome. Franceschini G, Masetti R. Ann Chir Plast Esthet. 2019 Jun;64(3):283-284. doi: 10.1016/j.anplas.2019.03.006. Epub 2019 Apr 17. (IF: 0.752)
84. Extreme oncoplastic breast conserving surgery: Is surgical dexterity all that is need? Franceschini G, Masetti R. Am J Surg. 2020 Jan; 219(1):211-212. doi: 10.1016/j.amjsurg.2019.04.008. Epub 2019 Apr 15. (IF: 2.125)
85. Internal surgical use of biodegradable carbohydrate polymers. Warning for a conscious and proper use of oxidized regenerated cellulose. Franceschini G. Carbohydr Polym. 2019 Jul 15;216:213-216. doi: 10.1016/j.carbpol.2019.04.036. Epub 2019 Apr 9. (IF: 7.182)
86. Breast-conservation Therapy After Neoadjuvant Chemotherapy: What the Surgeons Should Remember! Franceschini G, Masetti R. Am J Clin Oncol. 2019 Jun;42(6):546. doi: 10.1097/COC.0000000000000545. (IF: 1.907)
87. Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours. Franceschini G, Masetti R. Re: ANZ J Surg. 2019 Jun;89(6):786. doi: 10.1111/ans.15269. (IF: 1.355)
88.Comment on "Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer". Franceschini G, Di Leone A, Masetti R. Int J Breast Cancer. 2019 Jun 2;2019:4693794. doi: 10.1155/2019/4693794. eCollection 2019.
89. Nipple-sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique. Franceschini G, Visconti G, Garganese G, Barone-Adesi L, Di Leone A, Sanchez AM, Terribile D, Salgarello M, Masetti R. Breast J. 2020 Feb;26(2):206-210. doi: 10.1111/tbj.13529. Epub 2019 Sep 9. (IF: 1.991)
90. Oncoplastic Breast-Conserving Surgery: Is Technical Skill All That Is Needed? Franceschini G, Masetti R. Ann Plast Surg. 2019 Sep 12. doi: 10.1097/SAP.0000000000001986. (IF: 1.354)
91. Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability? Sanchez AM, Franceschini G, D'Archi S, De Lauretis F, Scardina L, Di Giorgio D, Accetta C, Masetti R. Breast J. 2020 Feb;26(2):125-132. doi: 10.1111/tbj.13490. Epub 2019 Sep 27.(IF: 1.991)
92. Hormone replacement therapy: revisiting the risk of breast cancer. Franceschini G, Lello S, Masetti R. Eur J Cancer Prev. 2019 Sep 16. doi: 10.1097/CEJ.0000000000000548. (IF: 2.413)
93. Personalized medicine in breast cancer: a step forward. Sanchez AM, Franceschini G, Terribile D, D'Archi S, Scardina L, Masetti R. Ann Transl Med. 2019 Jul;7(Suppl 3):S138. doi: 10.21037/atm.2019.06.10. (IF: 3.297)
94. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance. Franceschini G. Eur J Surg Oncol. 2020 Jan;46(1):216-217. doi: 10.1016/j.ejso.2019.10.020. (IF: 3.959)
95. Menopausal hormone therapy: What should be kept in mind for a personalized choice in a shared decision-making. Franceschini G, Lello S, Di Leone A, Orlandi A, Masetti R. Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:191-192. doi: 10.1016/j.ejogrb.2019.12.004. Epub 2019 Dec 9. (IF: 1.868)
96. Oncoplastic Breast Reconstruction in Conservation Surgery: Steps to Follow for a Successful Work. Franceschini G, Masetti R. Indian J Surg Oncol. 2019 Dec;10(4):660- 661. doi: 10.1007/s13193-019-00968-9. Epub 2019 Aug 13.
97. Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? Orlandi A, Aroldi F, Garutti M, Di Dio C, Garufi G, Iattoni E, Palazzo A, Indellicati G, Franceschini G, Cassano A, Bria E, Tortora G. Breast J. 2019 Dec 31. doi: 10.1111/tbj.13740. (IF: 1.991)
98. Oncoplastic Breast-Conserving Surgery: Is Technical Skill All That Is Needed? Franceschini G, Masetti R. Ann Plast Surg. 2020 Jan 7. doi: 10.1097/SAP.0000000000002221. (IF: 1.354)
99. Evidence-based nipple-sparing mastectomy in patients with higher body mass index: Recommendations for a successful standardized surgery. Franceschini G, Masetti R. Am J Surg. 2020 Jan 7. pii: S0002-9610(20)30003-9. doi: 10.1016/j.amjsurg.2020.01.002. (IF: 2.125)
100. A Rare Case of Nipple-Areolar Complex Partial Necrosis following Micropigmentation: What to Learn? Starnoni M, Pinelli M, Franceschini G, De Santis G.Plast Reconstr Surg Glob Open. 2019 Nov 27;7(11):e2494. doi: 10.1097/GOX.0000000000002494.
101. Oral contraceptives and breast cancer risk: An overestimated risk? Franceschini G, Di Leone A, D'Archi S, Masetti R. Crit Rev Oncol Hematol. 2020 Mar;147:102876. doi: 10.1016/j.critrevonc.2020.102876. (IF: 5.833)
102. Evidence-based surgery to realize a successful extreme oncoplastic breast conservation. Franceschini G, Masetti R. Eur J Surg Oncol. 2020 May;46(5):924-925. doi: 10.1016/j.ejso.2020.02.003. (IF:3.959)
103. OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer. Sanchez AM, Orlandi A, Franceschini G, De Lauretis F, Terribile D, Franco A, Masetti R. Ann Palliat Med. 2020 Mar;9(2):510-511. doi: 10.21037/apm.2020.01.14. Epub 2020 Feb 16. PMID: 32075400. (IF: 1.681)
104. Therapeutic nipple-sparing mastectomy combined with endoscopic immediate prosthetic breast reconstruction via axillary incision. A further step towards an evidence-based and personalized surgery. Franceschini G, Visconti G, Garganese G, Adesi LB, Di Leone A, Sanchez MA, Ionta L, Salgarello M, Masetti R. Ann Ital Chir. 2020 Apr 8;9:S0003469X20032273. (IF: 0.793)
105. Update on the sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient. Franceschini G, Di Leone A, Sanchez AM, D'Archi S, Scardina L, Masetti R. Ann Ital Chir. 2020 Apr 8;9:S0003469X20032236. (IF: 0.793)
106. Magnetic Resonance Imaging prediction of large volume displacement oncoplastic surgery versus mastectomy in the treatment of breast cancer. Rella R, Bufi E, Belli P, Conti M, Scaldaferri A, Grippo C, Franceschini G, Terribile D, Giuliani M, Manfredi R. Ann Ital Chir. 2020 May 11;9:S0003469X20031577. (IF: 0.793)
107. Transaxillary Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction Using a Simplified Endoscopic Approach: Indications, Cosmetic Outcomes and Technical Refinements. Visconti G, Franceschini G, Bianchi A, Barone-Adesi L, Garganese G, Masetti R, Salgarello M.Visconti G, et al. Aesthetic Plast Surg. 2020 May 28. doi: 10.1007/s00266-020-01792-1. (IF: 1.798)
108. Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review. Marazzi F, Masiello V, Franceschini G, Bosello S, Moschella F, Smaniotto D, Luzi S, Mulé A, Gambacorta MA, Gremese E, Masetti R, Valentini V.Marazzi F, et al. Rep Pract Oncol Radiother. 2020 Jul- Aug;25(4):527-532. doi: 10.1016/j.rpor.2020.03.013.
109. Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis. Marazzi F, Barone R, Masiello V, Magri V, Mulè A, Santoro A, Cacciatori F, Boldrini L, Franceschini G, Moschella F, Naso G, Tomao S, Gambacorta MA, Mantini G, Masetti R, Smaniotto D, Valentini V. Clin Breast Cancer. 2020 Oct;20(5):e600-e611. doi: 10.1016/j.clbc.2020.04.012. Epub 2020 May 5. (2.647)
110. Low-grade myofibroblastic sarcoma of the breast. Scardina L, Franceschini G, Di Leone A, D'Archi S, Santoro A, Mulè A, Salvatorelli L, Magro G, Masetti R. Breast J. 2020 Jun 28. doi: 10.1111/tbj.13956. (IF: 1.991)
111. The impact of the COVID-19 pandemic on breast cancer patients awaiting surgery: Observational survey in an Italian University hospital. Magno S, Linardos M, Carnevale S, Dilucca M, Di Leone A, Terribile DA, Franceschini G, Masetti R. Breast J. 2020 Aug;26(8):1597-1602. doi: 10.1111/tbj.13889. Epub 2020 Jul 17. (IF: 1.991)
112. Recommendations for a careful use of oxidized regenerated cellulose and acellular dermal matrix in partial breast reconstruction. Gianluca Franceschini, Giuseppe Visconti, Sabatino D’Archi, Riccardo Masetti. Medicine. Medicine Correspondence Blog Wednesday, September 9, 2020.
113. Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach. Paris I, Di Giorgio D, Carbognin L, Corrado G, Garganese G, Franceschini G, Sanchez AM, De Vincenzo RP, Accetta C, Terribile DA, Magno S, Di Leone A, Bove S, Masetti R, Scambia G. Clin Breast Cancer. 2020 Jul 20:S1526-8209(20)30173-7. doi: 10.1016/j.clbc.2020.07.007. (IF: 2.647)
114. Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians. Marazzi F, Orlandi A, Manfrida S, Masiello V, Di Leone A, Massaccesi M, Moschella F, Franceschini G, Bria E, Gambacorta MA, Masetti R, Tortora G, Valentini V. Cancers (Basel). 2020 Aug 24;12(9):E2390. doi: 10.3390/cancers12092390. (IF: 6.126)
115. Compliance with Specific Recommendations and Tasks Reduces Nipple Necrosis Rates in Prepectoral Implant-Based Reconstruction After Nipple-Sparing Mastectomy. Franceschini G, Masetti R. Ann Surg Oncol. 2020 Sep 1. doi: 10.1245/s10434-020-09109- x. (IF: 4.061)
116. Treatment protocol to allow reconstructive breast surgery during COVID-19 pandemic. Sanchez AM, Scardina L, Franceschini G, Terribile D, Franco A, Salgarello M, Masetti R. Br J Surg. 2020 Sep 9. doi: 10.1002/bjs.11969. (IF: 5.676) 117. Performance of standardized tasks and evidence-based surgery may increase the chance of success in breast conserving treatment. Franceschini G. Gland Surg. 2020 Aug;9(4):1069-1071. doi: 10.21037/gs-20-523. (IF: 2.190)
118. Immediate implant-based breast reconstruction with acellular dermal matrix after conservative mastectomy: can a more effective alternative be used in the near future? Franceschini G, Masetti R. Eur J Surg Oncol. 2020 Oct 1:S0748-7983(20)30809-X. doi: 10.1016/j.ejso.2020.09.037. (IF: 3.959)
119.Evidence-based medicine is a valuable tool for a successful decision-making on riskreducing bilateral mastectomy. G. Franceschini. Hormone Molecular Biology and Clinical Investigation. DOI: https://doi.org/10.1515/hmbci-2020-0039 Published online: 12 Oct 2020.
IMPEGNO nel SOCIALE
RICONOSCIMENTI
BREVETTI
Cerca nel Blog
Contatti
I MIEI CONTATTIPer contattare il Prof Franceschini, invia una richiesta.
Prof. Gianluca Franceschini
Specialista in Chirurgia Toracica
Via D'Esempio 123 - Roma (RM) - 00123 - Zona D'Esempio
Telefono: +39 123 456 789 - +39 06 123 456 789
E-mail: gianlucafranceschini@esempio.com